# OnCo record nms-03305293 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nms-03305293/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "nms-03305293" ;
  schema:name "NMS-03305293"@en ;
  schema:alternateName "NMS-293"@en ;
  schema:description "NMS-03305293 is an experimental pill being studied to block a DNA-repair enzyme in cancer cells."@en ;
  schema:url <https://onco.cc/drugs/nms-03305293/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06931626>, <https://clinicaltrials.gov/study/NCT04910022>, <https://clinicaltrials.gov/study/NCT06930755>, <https://clinicaltrials.gov/study/NCT04182516>, <https://doi.org/10.1158/1535-7163.targ-23-lb_a12> ;
  onco:status "phase-2" ;
  onco:modality "Small-molecule PARP1 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/ovarian/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:trials <https://onco.cc/trials/nct06931626/>, <https://onco.cc/trials/nct04910022/>, <https://onco.cc/trials/nct06930755/>, <https://onco.cc/trials/nct04182516/> .